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Despite the important advances in perinatal care in the past decades, asphyxia remains a severe condition leading to significant mortality and morbidity. Estimated incidence 
of perinatal asphyxia is quite variable from one study to another. 
The reported incidence from hospital-based studies vary from 
5 to 10 per 1000 live births [1,2]. Moreover, asphyxia has been 
shown to be the third most common cause of neonatal death 
after preterm birth and severe infection. Organ dysfunction in 
asphyxiated neonates depends on the duration of asphyxia and 
the early management. Although the myocardium in neonate is 
preferentially perfused during an episode of asphyxia, when such 
compensatory mechanism becomes compromised, the papillary 
muscle and subendocardial area appear to be particularly 
vulnerable to hypoxic injury [3-5].
Transient myocardial ischemia is a recognized association 
of perinatal asphyxia, with an incidence from 30% to 80% 
in severely asphyxiated neonates [6,7]. The recognition of 
myocardial ischemia is far more difficult in neonates than in 
adults. However, few investigations such as electrocardiogram 
(ECG), echocardiography (ECHO), and elevated levels of cardiac 
enzymes (CK-MB and troponin) can detect ischemic insult to the 
heart.
Hence, the present study was conducted to evaluate the 
presence and extent of cardiac involvement in asphyxiated 
neonates to establish which clinical and laboratory parameters 
represented the reliable marker of cardiac damage in these 
patients.
MATERIALS AND METHODS
A hospital-based, prospective, nested case-control study was 
carried out in the neonatology unit of a tertiary care and referral 
institute of central India from October 2009 to September 2011. 
The cases and control were enrolled in the study after getting the 
approval of protocol from Institutional Ethical Committee and 
valid consent from parents. The study population comprised of 90 
cases with completed 37 weeks of gestation with perinatal asphyxia 
evidenced by 5 min Apgar score of 7 or less [8]. The cases were 
divided into three groups according to SARNAT scale [9] which 
is used for staging of hypoxic ischemic encephalopathy. Neonates 
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with gestational age <37 weeks, congenital heart diseases, other 
congenital malformations, and sick neonates were excluded from 
study. Cord blood gas facility was not available at this institute; 
hence, could not be performed. 90 full-term neonates delivered 
without any evidence of asphyxia (5 min Apgar score 9 or more) 
were enrolled as control which was matched with cases for 
gestational age, sex, and birth weight.
All the asphyxiated neonates were resuscitated according 
to guidelines recommended by the American Academy of 
Pediatrics. Gestational age was determined by New Ballard 
score [10], and neonates were screened for the presence of 
any major congenital malformation. On the second day of life 
(between 24 and 36 h), all neonates underwent ECG, ECHO, 
and enzyme estimation.
ECG
The 12-lead ECG was performed on a standard Schiller Cardiovit 
AT-101 12 lead machine after 24 h of birth. The ECG was 
evaluated by 2 independent observers who were unaware of 
clinical condition of patients. Tracing were analyzed according to 
criteria proposed by Jedeikin et al. [11]. Every 12-lead ECG were 
classified as follows.
Grade 1:  The presence of flat or inverted T-wave in one or two 
leads (except aVR)
Grade 2:  T-wave flat or inverted in 3 or more leads (except aVR)
Grade 3:  T-wave flat or inverted in 3 or more leads and ST 
depression or elevation >2 mm in at least 2 chest leads 
or Q-wave abnormality defined as duration >0.02 s or 
amplitude >25% of R-wave in one anterior or 3 chest 
leads
Grade 4:  Classical segmental infarction with abnormal Q-waves 
and markedly elevated ST-segment.
ECHO
ECHO evaluation was done on a standard Philips IE33 2D ECHO 
ultrasound imaging system using 50 Hz transducer for mono and 
two-dimensional imaging after 24 h of birth. All ECHOs was 
performed by the same cardiologist who was not aware about 
the clinical condition of patients. On M-mode images of the 
left ventricle, fractional shortening (FS) was determined by the 
formula.
FS = (LVED-LVES)/LVED
Where LVED is left ventricular, end-diastolic diameter and 
LVES is left ventricular end-systolic diameter.
The aortic flow curve was obtained using five chamber 
apical views. The following parameters of cardiac function were 
determined on each curve: Peak aortic velocity, mean acceleration, 
and stroke distance, namely, the area under the velocity curve, 
also known as velocity time integral. In addition, the function 
of the atrioventricular valve was assessed by Doppler study 
with particular reference to the presence of mitral and tricuspid 
regurgitation (TR). The pulmonary artery pressure was estimated 
using TR jet if TR was present. Thus, the following parameters of 
cardiac function were determined: (1) FS, (2) peak aortic velocity, 
(3) mean acceleration, and (4) stroke distance.
Enzyme Estimation
For enzyme estimation of creatine kinase isoenzyme, 2 ml of 
venous blood collected by venipuncture. CK-MB was measured 
by qualitative test based on immunological principle of inhibition 
of CK-M monomer. A standard kit by Rashmi Diagnostics Pvt. 
Ltd., Bengaluru was used for enzyme estimation.
All patients were followed up to discharge or death and 
immediate outcome calculated in term of survival and deaths.
Statistical Analysis
For echocardiographic parameters and enzyme values, the mean 
and standard deviation were calculated. Comparison between 
cases and controls as well as a comparison between groups were 
performed by one-way variance multiple comparison Bonferroni 
test. Unpaired t-test was used to compare patients who survived 
to those who died from Group III.
RESULTS
90 cases (term neonates who had APGAR score <7 at 5 min) and 
90 controls (term neonate who had APGAR score >9 at 5 min) 
were included in the study group. Cases were divided into three 
groups according to SARNAT scale and Group I consist 25, 
Group II - 54, and Group III - 11 cases. The mean gestational 
age was 36.97±0.35 and 37.12±0.46 week for cases and controls 
respectively while mean birth weight was 2.79±0.36 kg and 
2.68±0.76 kg for cases and controls, respectively. Of the 90 
cases, 18 had low birth weight, and 72 had a birth weight >2.5 kg. 
The lowest and highest birth weights were 2.2 kg and 3.4 kg, 
respectively. The male to female sex ratio was 1.25:1 in both 
cases and controls.
ECG changes of Grades 3 and 4 were present in only 
Group III infants with the incidence of 63.66% and all neonates 
with Grade 4 changes were died in the 1st week of life. ECG from 
Group III neonates showing small Q-waves in lead II, III, aVF, 
V2, and diffuse ST-T segment elevation. (Table 1)
FS decreased progressively from Group I to Group III 
(p<0.001) and showed significant difference between cases and 
controls as well as in different groups except in controls versus 
Group I. Peak aortic velocity behaved similarly and showed 
significant difference between cases and controls as well as in 
different groups except in Group I versus Group II. Concerning 
mean acceleration, the significant difference was observed 
between control and cases (all 3 groups). Analysis of stroke 
distance did not reveal any significant difference among all 
3 groups. TR was observed in two neonates in Group I (8%), three 
in Group II (5.5%) and three in Group III (27.27%). Pulmonary 
hypertension was present in one and two neonates in Group II 
and III, respectively. The CK-MB activity increased from Group I 
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to Group III and statistically significant difference was seen in 
controls and different groups as well as in between different 
groups except in controls versus Group I (Tables 2 and 3).
There was no mortality in Groups I and II. Among 11 neonates 
in Group III, five neonates (45.45%) have died and 6 (54.54%) 
survived. Comparison of these subgroups (non-survivors vs. 
survivors) revealed no significant difference in ECHO parameters, 
but the CK-MB level was significantly higher (p=0.037) in an 
infant whose outcome was unfavorable and most of the neonates 
with unfavorable outcome had multiorgan dysfunction.
DISCUSSION
Perinatal asphyxia remains one of the most important fields of 
research for pediatricians, and innumerable studies have been 
conducted on the various aspect of perinatal asphyxia. However, 
cardiac dysfunction in asphyxia is a neglected area with very few 
clinical studies on it because infants with cardiac dysfunction are 
those who are severely asphyxiated. The clinical picture among 
them is dominated by neurological changes resulting in high 
mortality. The contribution of cardiac dysfunction to mortality 
and the fate of cardiac status among the survivors have not been 
extensively evaluated. Hence, this study in tertiary care institute 
attempts to exemplify the magnitude and the nature of cardiac 
dysfunction in perinatal asphyxia and to evaluate clinical and 
laboratory parameters which are reliable predictors of myocardial 
ischemia.
In the present study, both groups (cases and controls) were 
comparable with each other with respect to sex, birth weight as 
controls were matched and selected. A similar type of comparable 
study was reported by Rajakumar et al. [12].
In this study, electrocardiographic (ECG) changes were 
present in 70 (77.7%) of cases. Previous studies have given wide 
variation in the incidence ranging from 45% by Pal et al. [13], to 
73.3% by Rajakumar et al. [12], and 76.7% by Agrawal et al. [6]. 
The significant Q-wave was present in 3 (3.33%) in our study 
and Rajakumar et al. have reported 10% incidence of Q-waves. 
This corresponds to Grade 4 of Jedeikin grading criteria. These 
Q-waves were found in inferior leads-III and aVF suggesting 
inferior wall infarction. There has been no study, which clearly 
delineates which part of ventricular wall is damaged in perinatal 
asphyxia. Further studies are required to identify the particular 
patterns of infarction seen in asphyxia.
An important role is played by ECHO which may show 
two basic pattern representative of myocardial damage: (1) A 
depressed left ventricular function, expressed by reduction in 
both FS and aortic velocity (2) TR, eventually associated with 
pulmonary hypertension. M-mode Doppler imaging allows 
measurement of FS and ejection fraction (EF), which are more 
quantitative measures of the contractility of the ventricles. In a 
group of asphyxiated neonates, there was a gradual decrease in the 
FS with increasing degree of asphyxia in this study. Similar trends 
were also seen in aortic peak velocity and the mean acceleration 
used as the indices of left ventricular function. These results were 
similar to the ventricular dysfunction trends as represented by 
Barberi et al. [14].
Although a mild TR is relatively common in normal newborn 
infants, a moderate to severe valve insufficiency is often associated 
with pulmonary hypertension, as in some of our Group II and III 
neonates (1 from Group II and 2 from Group III). Barberi et al. 
studied cardiac involvement in asphyxiated neonate using ECG, 
ECHO, and cardiac enzyme reported FS, peak aortic velocity and 
mean acceleration were significantly reduced in severe asphyxia, 
Table 3: Comparison of ECHO parameters and serum CK-MB in cases and controls (p-value)
Study population FS (%) Peak aortic velocity (cm/s) Mean acceleration (cm/s2) Stroke distance CK-MB
Control versus Group I 0.1 0.002 0.0001 0.0001 1.000
Control versus Group II 0.0001 <0.0001 0.0001 0.0001 <0.001
Control versus Group III 0.0001 <0.0001 0.000 0.005 0.001
Group I versus Group II <0.0001 0.131 0.291 1.00 0.000
Group II versus Group III <0.0001 0.05 1.000 1.00 0.000
Group I versus Group III <0.0001 0.001 0.186 1.00 0.000
ECHO: Echocardiographic, FS: Fractional shortening
Table 2: ECHO parameters and CK-MB isoenzyme (mean±SD) in cases and controls
Study population FS (%) Peak aortic velocity (cm/s) Mean acceleration (cm/s2) Stroke distance (cm) CK-MB (IU/L)
Controls 39.2±3.28 81.88±10.18 1117.08±101.70 9.212±1.55 13.92±2.89
Group I 37.7±3.17 80.24±6.14 1462.24±153.99 11.36±0.91 14.92±3.44
Group II 29.8±3.74 74.96±9.66 1387.67±215.74 11.00±1.44 137.65±102.81
Group III 20.1±3.40 66.64±8.51 1394.73±116.91 10.94±0.98 345±242.18
ECHO: Echocardiographic, SD: Standard deviation, FS: Fractional shortening
Table 1: ECG changes in cases (3 HIE groups) and controls
Study 
population
n Normal 
(n, %)
ECG changes (n, %)
Grade 1 Grade 2 Grade 3 Grade 4 
Controls 90 81 (90) 9 (10) - - -
Group I 25 20 (80) 4 (16) 1 (4) - -
Group II 54 - 2 (3.7%) 52 (96.3) - -
Group III 11 - - 4 (36.36) 4 (36.36) 3 (27.3)
HIE: Hypoxic ischemic encephalopathy, ECG: Electrocardiogram
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whereas the only abnormality found in moderate asphyxia was a 
reduced FS. In this study, FS and peak aortic velocity decrease 
progressively from Group I to Group III. Analysis of stroke 
distance and mean acceleration did not reveal any significant 
difference among three groups.
TR and pulmonary hypertension were documented in 11 
(22.22%) cases in the present study. The most common finding 
was TR in 8 (8.8%) cases. This is less than that in the previous 
studies by Rowe et al. [15], Martein et al., and Rajakumar et al. 
who documented 12%, 21%, and 23.3%, respectively. However, 
Herdy et al. [16] have observed these changes in 7% of cases. TR 
could be due to papillary muscle ischemia or persistent pulmonary 
hypertension. The wide variation in the incidence of TR may be 
due to the type of cases selected, presence or absence of pulmonary 
hypertension and the timing of ECHO. Three neonates with TR 
had pulmonary hypertension by ECHO evaluation in our study, 
which could be contributed to TR. Although mitral regurgitation 
(MR) has been documented in previous studies (Rowe et al.), 
none of the babies in our study had MR.
Creatinine kinase is released during muscular trauma and 
myopathic disorder as well as myocardial infarction. In neonates, 
the total CK activity rises dramatically after delivery and falls to 
normal after 2-3 days [17]. Because of the association between 
the height of CK peak and obstetric difficulties, the peripartum 
release of this enzyme is generally thought to be due to muscle 
trauma, with or without anoxic damage. In adults, CK-MB is 
relatively specific to the myocardium. CK-MB release during 
newborn period has been studied by Jouppila et al. [18] who did 
not find significant elevation in the fractional CK-MB level during 
the first 3 days of life in healthy infants. Cuestas [19] mentioned 
the extreme elevation of CK-MB activity in some asphyxiated 
neonates. Nelson et al. using a single sample found the elevation 
of fractional and absolute CK-MB activities in the first few days 
of life in some infant with asphyxia.
Cardiac enzyme was estimated in all cases and controls. CK-MB 
estimated in the study was significantly elevated in cases when 
compared to controls. Mean CK-MB level among cases and controls 
were 122.46 IU/L and 13.92 IU/L, respectively. This is lower than 
the value reported by Agrwal (147±161.0 IU/L), Rajakumar et 
al. [20] (121±77.4 IU/L in cases and 28.8±20.2 IU/L in controls), 
Mandal Ravi et al. [21] (823.5 IU/L in cases), and Fonseca et al. [22] 
212±90.8 IU/L in cases and 106±48.1 IU/L in controls).
The CK-MB activity increased from Group I to Group II 
and statistically significant difference was seen in controls and 
different groups as well as in between different groups. Thus, 
indicating CK-MB is a very sensitive marker of myocardial 
ischemia. Whereas Barberi et al. observed that CK, CK-MB, 
CK-MB/CK ratio and lactate dehydrogenase were all increases in 
Group III, while only in Group II only CK-MB and the CK-MB/
CK ratio were abnormal.
Main limitation of our study was that estimation of cardiac 
enzyme troponin T, which is very specific for myocardial 
ischemia, was not done because of financial constraints as this 
facility was not available in our institute and study population 
belonged to poor socioeconomic class.
CONCLUSION
Severely asphyxiated neonates reflect relevant ischemic ECG 
changes, depressed left ventricular function, and marked cardiac 
enzyme increases. These alterations are far less pronounced in 
neonates with mild to moderate asphyxia. Our results suggest 
that severe ECG changes (Grades 3 and 4) are present only in 
very sick neonates, and should be considered as a specific marker 
of severe myocardial injury. CK-MB elevation and reduced FS 
should be regarded as most reliable marker of ischemia as they are 
detectable even in mildly compromised neonates. Asphyxiated 
neonates with Grades 3 and 4 ECG changes and high CK-MB 
activity have very poor prognosis due to extensive myocardial 
damage and concomitant multiorgan involvement.
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